Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion type Assertion NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_head.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion description "[Here we show that reduced gene dosage of NR4A1 and NR4A3 in hypoallelic (NR4A1(+/-)NR4A3(-/-) or NR4A1(-/-)NR4A3(+/-)) mice below a critical threshold leads to a chronic myeloid malignancy that closely recapitulates the pathologic features of mixed myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) with progression to AML in rare cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion evidence source_evidence_literature NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion SIO_000772 21205929 NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion wasDerivedFrom befree-2016 NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.
- NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_assertion wasGeneratedBy ECO_0000203 NP863161.RADQFbPgYTMd8hle2lPfJMwLv6gBb1Mg1M4p6IJr5_I5A130_provenance.